101 venture capitalism

933 views

Published on

An introduction to ventures and the way they are funded.

Published in: Business, Economy & Finance
0 Comments
4 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
933
On SlideShare
0
From Embeds
0
Number of Embeds
6
Actions
Shares
0
Downloads
28
Comments
0
Likes
4
Embeds 0
No embeds

No notes for slide
  • Marc ZuckerbergDustin MascovitzChris HughesSean Parker > Napster & PlaxoMarc Pincus > ZyngaReid HoffmannJim BryerYuri MilnerJohn DoerrFundingTotal $2.34BAngel, 9/04 21Peter ThielReid Hoffman$500kSeries A, 5/05 22Accel PartnersMark PincusReid Hoffman$12.7MSeries B, 4/06 23Greylock PartnersMeritech Capital PartnersFounders Fund$27.5MSeries C, 10/07 24Microsoft$240MSeries C, 11/07 25Li Ka-shing$60MSeries C, 1/08 26European Founders Fund$15MSeries C, 3/08 27Li Ka-shing$60MDebt, 5/08 28TriplePoint Capital$100MSeries D, 5/09 29Digital Sky Technologies$200MUnattributed, 6/10 30Elevation Partners$120MUnattributed, 1/11 31Goldman SachsDigital Sky Technologies$1.5B
  • Robert A SwansonDr. Herbert W. BoyerJohn DoerrArthur D. LevinsonLevinson joined Genentech in 1980 as a research scientist and became vice president, Research Technology in 1989; vice president, Research in 1990; senior vice president, Research in 1992; and senior vice president, Research and Development in 1993.In 1995, Levinson became Genentech’s chief executive officer, and in 1999 he was named chairman.http://www.gene.com/gene/about/corporate/history/index.htmlGenentech was founded more than 35 years ago, in 1976, by the late venture capitalist Robert A. Swanson and the biochemist Dr. Herbert W. Boyer. In the early 1970s, Boyer and geneticist Stanley Cohen pioneered a new scientific field called recombinant DNA technology. Upon learning about this development, Swanson placed a call to Boyer and requested a meeting. Boyer agreed to give the young entrepreneur 10 minutes of his time. Swanson's enthusiasm for the technology and his faith in its commercial potential were contagious, and the meeting extended from 10 minutes to three hours; by its conclusion, Genentech was born. Though Swanson and Boyer faced skepticism from both the academic and business communities, they forged ahead with their idea.
  • Linda AveyAnne WojcickiSergeyBrinArt LevinsonLinda Avey (born 1961) is an American biotech analyst, biologist, and the co-founder of 23andMe.Avey spent 20 years in sales and business development in biopharmaceuticals. Avey helped develop research programs for Affymetrix and Perlegen Sciences.[1]In 2006, she co-founded 23andMe with Anne Wojcicki.[2] In September 2009, Avey left 23andMe to start research on Alzheimer's; her father-in-law had recently died of the disease[3]Anne E. Wojcicki (pronounced /woʊˈdʒɪtski/ woh-jit-skee; born July 28, 1973)[1] is an American biotech analyst, biologist, and the co-founder of 23andMe.Wojcicki is the daughter of educator Esther Wojcicki and Stanley Wojcicki, a Polish American physics professor at Stanford University. She attended Gunn High School in Palo Alto, California, where she was one of three students voted Most Likely to Succeed in the 1991 yearbook.[2] She went on to graduate from Yale University with a B.S. in biology in 1996.[3]After graduating, Wojcicki worked 10 years overseeing healthcare investments, focusing on biotechnology companies. In 2006, she left the investing world to co-found 23andMe with Linda Avey.[4]Wojcicki married Google co-founder Sergey Brin in May 2007. They have a son, Benji, born in December 2008.Total $52.6MSeries A, 5/07 1GenentechGoogleMohr Davidow VenturesNew Enterprise Associates$9MSeries B, 6/09 2GoogleSergey Brin$12.6MSeries C, 11/10 3Johnson & Johnson Development CorporationNew Enterprise AssociatesGoogle Ventures$22MSeries C, 1/11 4Johnson & Johnson Development$9M
  • 101 venture capitalism

    1. 1. 101 Venture Capitalism Photo by: Vujàdé Ltd – Jasper BouwsmaAn introduction to ventures and the way they are funded.Jasper BouwsmaFounder & CEOVujàdé Ltd.Delft, The Netherlands © Vujàdé Ltd. – Supporting Forward Thinking www.vujade.com Slide |
    2. 2. Vu-jà-dé Photo by: Vujàdé Ltd. – Jasper Bouwsma Vujàdé is the opposite of déjà-vu and refers to something that has not yet taken place or has not yet existed. Looking for new solutions. Critically questioning existing structures and behavior. Looking at something from a different or an unusual point of view. In other words: Vujàdé stands for innovation.Photo by: Vujàdé Supporting Forward Thinking © Vujàdé Ltd. – Ltd – Jasper Bouwsma Slide | 2
    3. 3. AGENDA 1 2 3© Vujàdé Ltd. – Supporting Forward Thinking Slide | 3
    4. 4. REVENUE TIME © Vujàdé Ltd. – Supporting Forward Thinking Slide | 4
    5. 5. REVENUE THE VALLEY OF DEATH TIME © Vujàdé Ltd. – Supporting Forward Thinking Slide | 5
    6. 6. © Vujàdé Ltd. – Supporting Forward Thinking Slide | 6
    7. 7. Seed Capital Early Stage Later Stage Exit Schumpeter VC FFF & Angels IPO Wallstreet (M&A, Strategic Alliances)© Vujàdé Ltd. – Supporting Forward Thinking Slide | 7
    8. 8. D C B A0 1 2 3 Seed Capital Early Stage Later Stage Exit Schumpeter VC FFF & Angels IPO Wallstreet (M&A, Strategic Alliances)© Vujàdé Ltd. – Supporting Forward Thinking Slide | 8
    9. 9. D C B A $0 1 2 3 Seed Capital Early Stage Later Stage Exit Market VC FFF & Angels IPO Wallstreet (M&A, Strategic Alliances)© Vujàdé Ltd. – Supporting Forward Thinking Slide |
    10. 10. D C B A $0 1 2 3 Seed Capital Early Stage Later Stage Exit Market VC FFF & Angels IPO Wallstreet (M&A, Strategic Alliances)© Vujàdé Ltd. – Supporting Forward Thinking Slide | 10
    11. 11. AGENDA 1 2 3© Vujàdé Ltd. – Supporting Forward Thinking Slide | 11
    12. 12. © Vujàdé Ltd. – Supporting Forward Thinking Slide |
    13. 13. Li Ka-Shing 0 1 A B C D 2 3Entrepreneurs Seed Capital Early Stage Later Stage Exit Market VC Founders FFF & Angels IPO Wallstreet (M&A, Strategic Alliances)© Vujàdé Ltd. – Supporting Forward Thinking Slide | 13
    14. 14. © Vujàdé Ltd. – Supporting Forward Thinking Slide | 14
    15. 15. AGENDA 1 2 3© Vujàdé Ltd. – Supporting Forward Thinking Slide | 15
    16. 16. © Vujàdé Ltd. – Supporting Forward Thinking Slide |
    17. 17. 1976Scientists Entrepreneurs Seed Capital Early Stage Later Stage Exit MarketVisionaries Founders FFF & Angels VC IPO Wallstreet © Vujàdé Ltd. – Supporting Forward Thinking Slide | 17
    18. 18. 2007Scientists Entrepreneurs Seed Capital Early Stage Later Stage Exit “Schumpeter”Visionaries Founders FFF & Angels VC IPO Wallstreet © Vujàdé Ltd. – Supporting Forward Thinking Slide | 18
    19. 19. © Vujàdé Ltd. – Supporting Forward Thinking Slide |
    20. 20. FUNDS PEOPLE RAISED EMPLOYED unknown 11’000 ppl USD 25.1M 31’000 ppl USD 2.34B 1’000 ppl USD 52.6M 30 ppl© Vujàdé Ltd. – Supporting Forward Thinking Slide | 20
    21. 21. © Vujàdé Ltd. – Supporting Forward Thinking Slide | 21
    22. 22. Photo by: Vujàdé Ltd. – Jasper Bouwsma © Vujàdé Ltd. – Supporting Forward Thinking Slide |
    23. 23. Vujàdé Ltd.Postal AddressP.O. Box 4CH-3257 GrossaffoltermVisiting Address Photo by: Vujàdé Ltd – Jasper BouwsmaElfenaustrasse 3CH-2502 Biel/Bienne+41 (0)32 323 23 00Onlinewww.vujade.comcontact@vujade.comVujadeLtd © Vujàdé Ltd. – Supporting Forward Thinking Slide |

    ×